JP Morgan Chase
FCSC

JP Morgan Chase’s Fibrocell Science Inc. FCSC Stock Holding History

JP Morgan Chase’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-160
Closed -$3K – 5674
2017
Q3 		$3K Buy
160
+120
+300% +$1.94K ﹤0.01% 4857
2017
Q2 		$1K Buy
+40
New +$494 ﹤0.01% 4907
2013
Q3 		– Sell
-803
Closed -$74K – 4496
2013
Q2 		$74K Buy
+803
New +$66.4K ﹤0.01% 4215

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

JP Morgan Chase's FCSC Position: Q4 2017 in Review

JP Morgan Chase sold out of Fibrocell Science Inc. (FCSC) in Q4 2017, closing a stake of 160 shares — an estimated $3K sold.

JP Morgan Chase first reported a position in FCSC in Q2 2013 and held it in 3 quarters. The position peaked at $74K in Q2 2013. 32 funds tracked by Wall St. Rank hold FCSC as of Q4 2017.

  • JP Morgan Chase reported no remaining Fibrocell Science Inc. position as of Q4 2017 after selling out during the quarter.
  • JP Morgan Chase sold 160 Fibrocell Science Inc. shares in Q4 2017, an estimated $3K.
  • JP Morgan Chase first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 3 quarters.
  • JP Morgan Chase's Fibrocell Science Inc. position peaked at $74K in Q2 2013.
  • 32 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2017.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.